Kailera Reports Third-Quarter 2026 Financial Results
Kailera Therapeutics reported financial results for the quarter ended September 30, 2026.
Story updates
09:09:11 PM UTC
SquawkNews
Kailera reported a Q3 2026 net loss of $95.7M, versus $39.6M in Q3 2025. Cash, cash equivalents and marketable securities were $1,037.6M at September 30, 2026, expected to fund operations into mid-2028.Material DetailsContext by AI AnalystThe results show a clinical-stage company investing more hea…